These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 25755418)

  • 1. Microsomal Epoxide Hydrolase Polymorphisms and Haplotypes as Determinants of Hepatitis B Virusand Hepatitis C Virus-related Liver Disease in Indian Population.
    Rahat B; Kiran M; Saxena R; Chawla YK; Sharma RR; Kaur J
    J Clin Exp Hepatol; 2012 Jun; 2(2):104-11. PubMed ID: 25755418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutathione-S-transferase and microsomal epoxide hydrolase polymorphism and viral-related hepatocellular carcinoma risk in India.
    Kiran M; Chawla YK; Kaur J
    DNA Cell Biol; 2008 Dec; 27(12):687-94. PubMed ID: 18816171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haplotypes of microsomal epoxide hydrolase and x-ray cross-complementing group 1 genes in Indian hepatocellular carcinoma patients.
    Kiran M; Chawla YK; Jain M; Kaur J
    DNA Cell Biol; 2009 Nov; 28(11):573-7. PubMed ID: 19754350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha-fetoprotein as a tumor marker in hepatocellular carcinoma: investigations in south Indian subjects with hepatotropic virus and aflatoxin etiologies.
    Murugavel KG; Mathews S; Jayanthi V; Shankar EM; Hari R; Surendran R; Vengatesan A; Raghuram K; Rajasambandam P; Murali A; Srinivas U; Palaniswamy KR; Pugazhendhi T; Thyagarajan SP
    Int J Infect Dis; 2008 Nov; 12(6):e71-6. PubMed ID: 18658001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms of microsomal epoxide hydrolase gene and severity of HCV-related liver disease.
    Sonzogni L; Silvestri L; De Silvestri A; Gritti C; Foti L; Zavaglia C; Bottelli R; Mondelli MU; Civardi E; Silini EM
    Hepatology; 2002 Jul; 36(1):195-201. PubMed ID: 12085365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.
    Zhang JY; Dai M; Wang X; Lu WQ; Li DS; Zhang MX; Wang KJ; Dai LP; Han SG; Zhou YF; Zhuang H
    Int J Epidemiol; 1998 Aug; 27(4):574-8. PubMed ID: 9758109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C virus in chronic liver disease and hepatocellular carcinoma in Taiwan.
    Chen DS
    Princess Takamatsu Symp; 1995; 25():27-32. PubMed ID: 8875606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Etiological and molecular profile of hepatocellular cancer from India.
    Asim M; Sarma MP; Kar P
    Int J Cancer; 2013 Jul; 133(2):437-45. PubMed ID: 23233429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TLR3 and TLR4 SNP variants in the liver disease resulting from hepatitis B virus and hepatitis C virus infection.
    Sghaier I; Zidi S; Mouelhi L; Ghazoueni E; Brochot E; Almawi WY; Loueslati BY
    Br J Biomed Sci; 2019 Jan; 76(1):35-41. PubMed ID: 30421643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-6(-572/-597) polymorphism and expression in HBV disease chronicity in an Indian population.
    Saxena R; Chawla YK; Verma I; Kaur J
    Am J Hum Biol; 2014; 26(4):549-55. PubMed ID: 24841049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for hepatocellular carcinoma in India.
    Kar P
    J Clin Exp Hepatol; 2014 Aug; 4(Suppl 3):S34-42. PubMed ID: 25755609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
    Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
    Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanism of hepatocarcinogenesis.
    Sheu JC
    J Gastroenterol Hepatol; 1997 Oct; 12(9-10):S309-13. PubMed ID: 9407351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P53 tumor suppressor gene mutations in hepatocellular carcinoma patients in India.
    Katiyar S; Dash BC; Thakur V; Guptan RC; Sarin SK; Das BC
    Cancer; 2000 Apr; 88(7):1565-73. PubMed ID: 10738214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profile of hepatocellular carcinoma in India: an insight into the possible etiologic associations.
    Sarin SK; Thakur V; Guptan RC; Saigal S; Malhotra V; Thyagarajan SP; Das BC
    J Gastroenterol Hepatol; 2001 Jun; 16(6):666-73. PubMed ID: 11422620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C and B virus infections in hepatocellular carcinoma. Analysis of direct detection of viral genome in paraffin embedded tissues.
    Edamoto Y; Tani M; Kurata T; Abe K
    Cancer; 1996 May; 77(9):1787-91. PubMed ID: 8646675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-1 polymorphism and expression in hepatitis B virus-mediated disease outcome in India.
    Saxena R; Chawla YK; Verma I; Kaur J
    J Interferon Cytokine Res; 2013 Feb; 33(2):80-9. PubMed ID: 23210983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variants in IL4RA, IL6, and IL12B genes and susceptibility to hepatitis B and C virus infections among Iraqi patients.
    Al-Saffar OB; Ad'hiah AH
    J Med Virol; 2020 Dec; 92(12):3448-3458. PubMed ID: 32652594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of viral genotypes and hepatitis B viral mutants in the risk of hepatocellular carcinoma associated with hepatitis B and C dual infection.
    Hung CH; Chen CH; Lee CM; Hu TH; Lu SN; Wang JH; Huang CM
    Intervirology; 2013; 56(5):316-24. PubMed ID: 23838434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of IL-12B, IL-2, TGF-β1, and IL-4 polymorphism and expression on hepatitis B progression.
    Saxena R; Chawla YK; Verma I; Kaur J
    J Interferon Cytokine Res; 2014 Feb; 34(2):117-28. PubMed ID: 24161121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.